Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prospects For 2010 New-Tech Inpatient Add-On Payments Appear Bleak

This article was originally published in The Gray Sheet

Executive Summary

Each of this year's applicants for new-technology add-on Medicare payments are a long shot, CMS suggests in its proposed 2010 inpatient payment 1rule

You may also be interested in...



Monteris Adds New Trial Data To Its Case For A New-Tech Payment

Monteris Medical CEO Jim Duncan shared data from a first-in-man study of the firm's AutoLITT tumor ablation catheter during a Feb. 19 new-technology town hall meeting at CMS headquarters in Baltimore

Monteris Adds New Trial Data To Its Case For A New-Tech Payment

Monteris Medical CEO Jim Duncan shared data from a first-in-man study of the firm's AutoLITT tumor ablation catheter during a Feb. 19 new-technology town hall meeting at CMS headquarters in Baltimore

Four Device Makers Apply For 2011 New-Technology Add-On Bonus

CMS has received five applications from four device firms for its next round of new-technology add-on payments, including submissions for two products that did not qualify for the extra payment during previous attempts

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel